Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gardasil Anal Cancer Indication To Face FDA Advisory Committee Scrutiny

This article was originally published in The Pink Sheet Daily

Executive Summary

Supplemental application filed earlier this year is part of Merck's strategy to broaden use of the HPV vaccine, although its bid to expand the label to women ages 27-45 has thus far been blocked by the agency.
Advertisement

Related Content

Gardasil Anal Cancer Indication: CBER Has No Concerns, But What Will ACIP Think?
Gardasil Anal Cancer Indication: CBER Has No Concerns, But What Will ACIP Think?
Gardasil Anal Cancer Indication: CBER Has No Concerns, But What Will ACIP Think?
Animal Rule's Effect On Anthrax Vaccines To Be Discussed By Advisory Committee
Merck Looks To Mid-June FDA Decision On Expanded Use Of Gardasil To Older Women
Cervarix Gets One Up On Gardasil In Cross-Protection: HPV-31 In FDA Approval
Gardasil Advisory Cmte. Has Advice On Marketing, Not Just PostMarket Trials
Gardasil Label Expansion To Women 27-45 Delayed Until 2010, At The Earliest
Gardasil Sails Through Committee; Discussions Center On Labeling Language
Gardasil Sails Through Committee; Discussions Center On Labeling Language

Topics

Advertisement
UsernamePublicRestriction

Register

PS071238

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel